Myopia Profile Launches Parent-Focused Treatment Guide on MyKidsVision.org

The Brisbane-based myopia education platform has expanded its consumer resources with a new product compendium designed to help families make sense of the growing myopia management landscape.

Myopia Profile has unveiled a new Myopia Control Product Compendium on its consumer-facing platform, MyKidsVision.org, giving parents and caregivers a centralised, evidence-based reference point for childhood myopia treatments.

The resource comes as eye care professionals (ECPs) report fielding an increasing volume of questions from parents who are independently researching myopia management options, often through online forums, before or between clinical appointments.

"As the number of myopia control options grows, many parents are feeling overwhelmed by the choices available," said Dr Kate Gifford, co-founder of Myopia Profile. "ECPs are fielding more questions from parents, who are becoming increasingly savvy about their children's eye health. The goal of the Myopia Control Product Compendium is to help parents navigate this information, provide clear guidance, and make the research less overwhelming."

The new consumer guide builds on the practitioner-facing Product Compendium already available on MyopiaProfile.com, translating clinical content into accessible, plain-language explanations suited to a non-clinical audience. Coverage spans six treatment categories: spectacles, soft contact lenses, orthokeratology (ortho-k), atropine, light therapies, and instruments and software; with age-specific guidance ranging from toddlers through to young adults.

Alongside the product listings, a series of newly developed "Parents' Guide" articles provides concise overviews of each treatment type and relevant diagnostic technologies, helping families understand how interventions work and what benefits they may offer.

Importantly for ECPs, the compendium has been designed to be non-comparative and modality-neutral. Myopia Profile states the resource is intentionally structured to avoid implying preference for any single treatment approach or disadvantaging any clinical setting, a consideration likely to reassure practitioners concerned about patients arriving with preconceived ideas shaped by commercially influenced content.

According to the company, the platform was shaped by feedback and engagement from thousands of ECPs, parents, and patients, suggesting the content has been stress-tested against real-world questions and concerns from across the myopia management community.

The Myopia Control Product Compendium is now live at www.mykidsvision.org/products.